Efficacy of Screening Mammography: A Meta-analysis

JAMA: The Journal of the American Medical Association

Volumn 273, Issue 2, 1995, Pages 149-154

  Kerlikowske, Karla ^a   Grady, Deborah ^a   Rubin, Susan M ^a   Sandrock, Christian ^a   Ernster, Virginia L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; BREAST CANCER; BREAST EXAMINATION; CANCER MORTALITY; CANCER RISK; CANCER SCREENING; CASE CONTROL STUDY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DATA BASE; FEMALE; FOLLOW UP; HUMAN; MAMMOGRAPHY; MEDICAL INFORMATION; META ANALYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; STATISTICAL ANALYSIS;

EID: 0028817211     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.1995.03520260071035     Document Type: Article

References (42)

1. O'Maley M, Fletcher S, Morrison B. Does Screening for Breast Cancer Save Lives? Effectiveness of Treatment After Breast Cancer Detection Following Screening by Clinical Breast Examination, Mammography and Breast Self-examination. New York, NY: Springer-Verlag New York Inc; 1990.
2. Tabar L, Fagerberg G, Duffy S, Day N, Gas A, Grontoft O. Update of the Swedish two county program of mammographic screening trial. Radiol Clin North Am. 1992;30:187-210.
3. Andersson I, Aspegren K, Janzon L, et al. Mammographic screening and mortality from breast cancer: the Malmo mammographic screening trial. BMJ. 1988;297:943-948.
4. Roberts MM, Alexander FE, Anderson TJ, et al. Edinburgh trial of screening for breast cancer: mortality at seven years. Lancet. 1990;335:241-246.
5. Frisell J, Eklund G, Hellstrom L, Lidbrink E, Rutqvist LE, Somell A. Randomized study of mammography screening: preliminary report on mortality in the Stockholm trial. Breast Cancer Res Treat. 1991;18:49-56.
6. Shapiro S. Periodic Screening for Breast Cancer: The Health Insurance Plan Project and Its Sequelae, 1963-1986. Baltimore, Md: Johns Hopkins University Press; 1988.
7. Miller AB, Baines CJ, To T, Wall C. Canadian National Breast Screening Study, 1: breast cancer detection death rates among women aged 40 to 49 years. Can Med Assoc J. 1992;147:1459-1476.
8. Nystrom L, Rutquvist LE, Wall S, et al. Breast cancer screening with mammography: overview of Swedish randomized trials. Lancet. 1993;341:973-978.
9. Fletcher SW, Black W, Harris R, Rimer BK, Shapiro S. Report of the International Workshop on Screening for Breast Cancer. J Natl Cancer Inst. 1993;85:1644-1656.
10. Sickles EA, Kopans DB. Deficiencies in the analysis of breast cancer screening data. J Natl Cancer Inst. 1993;85:1621-1624.
11. Bulpitt CJ. Meta-analysis. Lancet. 1988;2:93-94.
12. Smart CR, Hartmann WH, Beahrs OH, Garfinkel L. Insights into breast cancer screening of younger women. Cancer. 1993;72:1449-1456.
13. Letton AH, Mason EM. Five-year survival of breast screenees. Cancer. 1981;48:404-406.
14. Letton AH, Wilson JP, Mason EM. The value of breast screening in women less than fifty years of age. Cancer. 1977;40:1-3.
15. Seidman H, Gelb SK, Silverberg E, LaVerda N, Lubera JA. Survival experience in the breast cancer detection demonstration project. CA Cancer J Clin. 1987;37:258-290.
16. Baker LH. Breast cancer detection demonstration project: five-year summary report. CA Cancer J Clin. 1982;32:194-225.
17. Verbeek ALM, Hendriks JHCL, Holland R, Mravunac M, Sturmans F. Mammographic screening and breast cancer mortality: age-specific effects in Nijmegen project, 1975-82. Lancet. 1985;1:865-866.
18. Miller AB, Baines CJ, To T, Wall C. Canadian National Breast Screening Study, 2: breast cancer detection and death rates among women aged 50 to 59 years. Can Med Assoc J. 1992;147:1477-1488.
19. Collette HJA, de Waard F, Collette C, Day NE. Further evidence of benefits of a (non-randomized) breast cancer screening programme: the DOM project. J Epidemiol Community Health. 1992;46: 382-386.
20. Palli D, Del Turco MR, Buiatti E, Ciatto S, Crocetti E, Paci E. Time interval since last test in a breast cancer screening programme: a case-control study in Italy. J Epidemiol Community Health. 1989;43:241-248.
21. Moss SM, Summerley ME, Thomas BT, Ellman R, Chamberlain JOP. A case-control evaluation of the effect of breast cancer screening in the United Kingdom Trial of Early Detection of Breast Cancer. J Epidemiol Community Health. 1992;46:362-364.
22. Tabar L, Fagerberg G, Duffy SW, Day NE. The Swedish two county trial of mammographic screening for breast cancer: recent results and calculation of benefit. J Epidemiol Community Health. 1989; 43:107-114.
23. Shapiro S. Evidence on screening for breast cancer from a randomized trial. Cancer. 1977;39: 2772-2782.
24. Wald N, Chamberlain J, Hackshaw A, and EUSOMA Evaluation Committee. Report of the European Society for Mastology Breast-Cancer Screening Evaluation Committee. J Eur Soc Mastology. 1993;13:1-25.
25. Greenland S. Quantitative methods in the review of epidemiologic literature. Epidemiol Rev. 1987;9:1-30.
26. Elwood JM, Cox B, Richardson AK. The effectiveness of breast cancer screening by mammography in younger women. Online J Curr Clin Trials [Serial on line]. 1993;2:Doc NR 32.
27. van Dijck JAAM, Verbeek ALM, Hendriks JHCL, Holland R. One-view versus two-view mammography in baseline screening for breast cancer: a review. Br J Radiol. 1992;65:971-976.
28. Peeters PHM, Verbeek ALM, Hendriks JHCL, van Bon MJH. Screening for breast cancer in Nijmegen: report of 6 screening rounds, 1975-1986. Int J Cancer. 1989;43:226-230.
29. Sickles EA, Weber WN, Galvin HB, Ominsky SH, Sollitto RA. Baseline screening mammography: one vs two views per breast. AJR Am J Roentgenol. 1986;147:1149-1153.
30. Bassett LW, Bunnell DH, Jahanshahi R, Gold RH, Arndt RD, Linsman J. Breast cancer detection: one versus two views. Radiology. 1987;165: 95-97.
31. Frisell J, Glas U, Hellstrom L, Somell A. Randomized mammographic screening for breast cancer in Stockholm. Breast Cancer Res Treat. 1986; 8:45-54.
32. Andersson I, Janzon L, Sigfusson BF. Mammographic breast cancer screening: a randomized trial in Malmo, Sweden. Maturitas. 1985;7:21-9.
33. Moskowitz M. Breast cancer: age-specific growth rates and screening strategies. Radiology. 1986; 161:37-41.
34. Tabar L, Faberberg G, Day NE, Holmberg L. What is the optimum interval between mammographic screening examinations? an analysis based on the latest results of the Swedish two-county breast cancer screening trial. Br J Cancer. 1987; 55:547-551.
35. Chu KC, Smart CR, Tarone RE. Analysis of breast cancer mortality and stage distribution by age for the Health Insurance Plan clinical trial. J Natl Cancer Inst. 1988;80:1125-1132.
36. Stanford JL, Hartge P, Brinton LA, Hoover RN, Brookmeyer R. Factors influencing the age at natural menopause. J Chronic Dis. 1987;40:995-1002.
37. Whelan EA, Sandler DP, McConnaughey DR, Weinberg CR. Menstrual and reproductive characteristics and age at natural menopause. Am J Epidemiol. 1990;131:625-632.
38. Shapiro S, Venet W, Strax P, Venet L, Roeser R. Ten- to fourteen-year effect of screening on breast cancer mortality. J Natl Cancer Inst. 1982;69:349-355.
39. Peer PGM, Holland R, Hendriks JHCL, Mravunac M, Berbeek ALM. Age-specific effectiveness of the Nijmegen population-based breast cancer screening program: assessment of early indicators of screening effectiveness. J Natl Cancer Inst. 1994; 89:436-441.
40. Muir BB, Kirkpatrick AE, Roberts MM, Duffy SW. Oblique-view mammography: adequacy for screening. Radiology. 1984;151:39-41.
41. Andersson I, Hildell J, Muhlow A, Pettersson H. Number of projections in mammography: influence on detection of breast disease. AJR Am J Roentgenol. 1978;130:349-351.
42. UK Trial of Early Detection of Breast Cancer Group. Sensitivity and specificity of screening in the UK Trial of Early Detection of Breast Cancer. In: Miller AB, Chamberlain J, Day NE, Hakama M, Prorok PC, eds. Cancer Screening. New York, NY: University Press; 1991:3-17.